US FDA approves CYBERDYNE's lower limb medical device
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
The U.S. Food and Drug Administration approved CYBERDYNE Inc.'s hybrid assistive limb medical device.
The Hybrid assistive limb device is meant for people who have lower limb disorders or those whose legs are weakening.
